INDV
NEUTRALIndivior Director Increases Shareholding
The healthcare company has announced that one of its non-executive directors has purchased additional shares in the business.
Indivior
841.50GBX
-0.65%
Market Cap
1.08B
Volume
119.34k
31% of avg
P/E Ratio
6.57
EPS (TTM)
1.28
Beta
0.34
Day Range
0.00p - 0.00p
52 Week Range
0.00p841.50p1,485.00p
841.50p
Upcoming Events
Q4 2025
Estimated last subject last visit for INDV-6001 Phase 2 PK study
High Impact Event
INDV
NEUTRALIndivior Reports Q1 2025 Results; Guidance Unchanged
The healthcare company reported a 6% drop in Q1 revenue, citing generic competition and funding issues, but maintained its full-year guidance.
INDV
NEUTRALIndivior Announces Major Shareholding Change
The healthcare company has reported a change in major shareholding, with Rubric Capital Management LP increasing its stake in the firm.
INDV
NEUTRALIndivior to Announce Q1 2025 Results
The pharmaceutical company will release its Q1 2025 results and host a webcast on April 24th.
INDV
NEUTRALIndivior Announces Change in Substantial Shareholding
The healthcare company has announced a change in substantial shareholding by an investment management firm.
INDV
NEUTRALIndivior Announces Change in Substantial Shareholding
The healthcare company has announced a change in substantial shareholding by an investment management firm.
INDV
NEUTRALIndivior PLC Announces Notice of 2025 Annual General Meeting
The healthcare company has published the notice for its upcoming annual general meeting.
INDV
NEUTRALIndivior Announces Change in Substantial Shareholding
The healthcare company has announced a change in substantial shareholding, with Rubric Capital Management LP increasing its stake in the business.
INDV
NEUTRALIndivior Executives Receive Shares Under Deferred Bonus Plan
The healthcare company has announced the vesting and delivery of shares to two of its executives under a deferred bonus plan.
INDV
GOODIndivior PLC Publishes 2024 Annual Report
The pharmaceutical company has published its 2024 annual report, providing a comprehensive overview of its financial performance and operations over the past year.